Infectious Disease Traveler Mobile Application Based on Need Assessment Analysis in Malaysian Students
Abstract
Major risks to world health are posed by infectious illnesses such as leptospirosis, hepatitis, malaria, dengue, and tuberculosis. Many diverse measures have been taken to fight infectious disease. However, cases persist despite these efforts, emphasizing the necessity for creative methods of managing and preventing disease. As it integrates mobile health (mHealth) solutions, the research can potentially revolutionize travel medicine. It is vital to give easily accessible and trustworthy health information that can lower the risks of infectious disease while traveling, as the number of students and the general public who travel is increasing. It was qualitative research. Qualitative study explores the potential of mobile health (mHealth) solutions to enhance travel medicine by providing accessible and reliable information to mitigate infectious disease risks among travelers. There 39 informants for the research. The inclusion criteria includes persons with a history of traveling or plans to travel. The data was collected by using questionnaire, FGD, and in-depth interviews for qualitative analysis. Findings from 39 informants, collected through questionnaires, focus group discussions, and in-depth interviews, highlight the need for innovative, user-friendly applications to improve the quality and efficiency of health information for travel-related disease prevention and management. By incorporating mHealth solutions, travelers may receive higher-quality, more useful, and more efficient health information that may be used to manage travel-related health concerns.
Full text article
References
1. WHO. World Malaria Report. Geneva: World Health Organization; 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
2. Surendra H, Supargiyono, Ahmad RA, Kusumasari RA, Rahayujati TB, Damayanti SY, et al. Using Health Facility-Based Serological Surveillance to Predict Receptive Areas at Risk of Malaria Outbreaks in Elimination Areas. BMC Medicine. 2020;18 (9). https://doi.org/10.1186/s12916-019-1482-7
3. Paintain L, Hill J, Ahmed R, Umbu Reku Landuwulang C, Ansariadi A, Rini Poespoprodjo J, et al. Cost-Effectiveness of Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine Versus Single Screening and Treatment for The Control of Malaria in Pregnancy in Papua, Indonesia: A Provider Perspective Analysis from A Cluster-Randomised Trial. The Lancet Global Health. 2020;8(12):1524–1533. https://doi.org/10.1016/S2214-109X(20)30386-7
4. Ahmed R, Levy EI, Maratina SS, De Jong JJ, Asih PBS, Rozi IE, et al. Performance of Four HRP-2/pLDH Combination Rapid Diagnostic Tests and Field Microscopy as Screening Tests for Malaria in Pregnancy in Indonesia: A Cross-Sectional Study. Malaria Journal. 2015;14(420). https://doi.org/10.1186/s12936-015-0943-5
5. Ipa M, Laksono AD, Astuti EP, Prasetyowati H, Pradani FY, Hendri J, et al. Sub-National Disparities in Accessing Anti-Malarial Drug Treatment in Eastern Indonesia. BMC Public Health. 2021;21(1548). https://doi.org/10.1186/s12889-021-11602-1
6. Karyana M, Devine A, Kenangalem E, Burdarm L, Poespoprodjo JR, Vemuri R, et al. Treatment-Seeking Behaviour and Associated Costs for Malaria in Papua, Indonesia. Malaria Journal. 2016;15(536). https://doi.org/10.1186/s12936-016-1588-8
7. Assebe LF, Kwete XJ, Wang D, Liu L, Norheim OF, Jbaily A, et al. Health Gains and Financial Risk Protection Afforded by Public Financing of Selected Malaria Interventions in Ethiopia: An Extended Cost-Effectiveness Analysis. Malaria Journal. 2020;19(41). https://doi.org/10.1186/s12936-020-3103-5
8. Jiram AI, Ooi CH, Rubio JM, Hisam S, Karnan G, Sukor NM, et al. Evidence of Asymptomatic Submicroscopic Malaria in Low Transmission Areas in Belaga District, Kapit Division, Sarawak, Malaysia. Malaria Journal. 2019.18(156). https://doi.org/10.1186/s12936-019-2786-y
9. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The Global Distribution and Burden of Dengue. Nature. 2013;496(496):504–507. https://doi.org/10.1038/nature12060
10. Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The Global Economic Burden of Dengue: A Systematic Analysis. Lancet Infectious Diseases. 2016;16(8):935–941. https://doi.org/10.1016/S1473-3099(16)00146-8
11. O’Reilly KM, Hendrickx E, Kharisma DD, Wilastonegoro NN, Carrington LB, Elyazar IRF, et al. Estimating the Burden of Dengue and The Impact of Release of wMel Wolbachia-Infected Mosquitoes in Indonesia: a Modelling Study. BMC Medicine. 2019; 17(172). https://doi.org/10.1186/s12916-019-1396-4
12. Nadjib M, Setiawan E, Putri S, Nealon J, Beucher S, Hadinegoro SR, et al. Economic Burden of Dengue in Indonesia. Shepard DS, Editor. PLoS Neglected Tropical Diseases. 2019;13(1):e0007038. https://doi.org/10.1371/journal.pntd.0007038
13. WHO. Ending the Burden of Dengue Infection: Indonesia Launched The 2021-2025 National Strategic Plan for Dengue Control Programme. Geneva: World Health Organization; 2021. https://www.who.int/indonesia/news/detail/15-11-2021-ending-the-burden-of-dengue-infection-indonesia-launched-the-2021-2025-national-strategic-plan-for-dengue-control-programme
14. Liang Y, Ahmad Mohiddin MN, Bahauddin R, Hidayatul FO, Nazni WA, Lee HL, et al. Modelling the Effect of a Novel Autodissemination Trap on the Spread of Dengue in Shah Alam and Malaysia. Computational and Mathematical Methods in Medicine. 2019; 2019(1):1–15. https://doi.org/10.1155/2019/1923479
15. Greenhalgh D, Liang Y, Nazni WA, Teoh GN, Lee HL, Massad E. Modeling the Effect of a Novel Auto-Dissemination Trap on The Spread of Dengue in High-Rise Condominia, Malaysia. Journal of Biological Systems. 2018;26(04):553–578. https://doi.org/10.1142/S0218339018500250
16. WHO. Hepatitis B. Geneva: World Health Organization; 2025. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
17. Trickey A, Hiebert L, Perfect C, Thomas C, El Kaim JL, Vickerman P, et al. Hepatitis C Virus Elimination in Indonesia: Epidemiological, Cost and Cost‐Effectiveness Modelling to Advance Advocacy and Strategic Planning. Liver International. 2019;40(2):286–297.
https://doi.org/10.1111/liv.14232
18. Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global Prevalence of Injecting Drug Use and Sociodemographic Characteristics and Prevalence of HIV, HBV, and HCV in People Who Inject Drugs: A Multistage Systematic Review. Lancet Global Health. 2017;5(12): 1192–207. https://doi.org/10.1016/S2214-109X(17)30375-3
19. Muhamad NA, Ab. Ghani RM, Abdul Mutalip MH, Muhammad EN, Mohamad Haris H, Mohd Zain R, et al. Seroprevalence of Hepatitis B Virus and Hepatitis C Virus Infection Among Malaysian Population. Scientific Reports. 2020;10(21009). https://doi.org/10.1038/s41598-020-77813-5
20. Rajamoorthy Y, Mohd Taib N, Rahim K, Munusamy S. Trends and Estimation of Hepatitis B Infection Cases in Malaysia, 2003-2030. Malaysian Journal of Public Health Medicine. 2016;16(1):113–120. https://www.researchgate.net/publication/319664509_Trends_and_estimation_of_hepatitis_B_infection_cases_in_Malaysia_2003-2030
21. Raihan R, Azzeri A, Shabaruddin FH, Mohamed R. Hepatocellular Carcinoma in Malaysia and Its Changing Trend. Euroasian Journal of Hepato-Gastroenterology. 2018;8 (1):54–56. https://doi.org/10.5005/jp-journals-10018-1259
22. Ho JY, Lavinya AA, Kay DSW, Lee CIS, Razmi AH, Walsh CL, et al. Towards an Integrated Approach to Improve the Understanding of the Relationships Between Water-Borne Infections and Health Outcomes: Using Malaysia as a Detailed Case Study. Frontiers Water. 2022;4:779860. https://doi.org/10.3389/frwa.2022.779860
23. Benacer D, Thong KL, Verasahib KB, Galloway RL, Hartskeerl RA, Lewis JW, et al. Human Leptospirosis in Malaysia: Reviewing the Challenges After 8 Decades (1925-2012). Asia Pacific Journal of Public Health. 2016;28(4):290–302. https://doi.org/10.1177/1010539516640350
24. Mohd Radi MF, Hashim JH, Jaafar MH, Hod R, Ahmad N, Mohammed Nawi A, et al. Leptospirosis Outbreak After the 2014 Major Flooding Event in Kelantan, Malaysia: A Spatial-Temporal Analysis. American Journal of Tropical Medicine and Hygiene. 2018; 98(5):1281–1295. https://doi.org/10.4269/ajtmh.16-0922
25. WHO. Leptospirosis Prevention and Control in Indonesia. Geneva: World Health Organization; 2020. https://www.who.int/indonesia/news/detail/24-08-2020-leptospirosis-prevention-and-control-in-indonesia
26. Kemenkes RI. Profil Kesehatan Indonesia Tahun 2018. Jakarta: Kementerian Kese-hatan RI; 2019. https://kemkes.go.id/id/profil-kesehatan-indonesia-2018
27. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Neglected Tropical Diseases. 2015;9(9): e0003898. https://doi.org/10.1371/journal.pntd.0003898
28. Gasem MH, Hadi U, Alisjahbana B, Tjitra E, Hapsari MMDEAH, Lestari ES, et al. Leptospirosis in Indonesia: Diagnostic Challenges Associated with Atypical Clinical Manifestations and Limited Laboratory Capacity. BMC Infectious Diseases. 2020;20 (179). https://doi.org/10.1186/s12879-020-4903-5
29. WHO. Accelerating Progress on HIV, Tuberculosis, Malaria, Hepatitis and Neglected Tropical Diseases. Geneva: World Health Organization; 2015. https://www.who.int/publications/i/item/accelerating-progress-on-hiv-tuberculosis-malaria-hepatitis-and-neglected-tropical-diseases
30. Bandzuh JT, Ernst KC, Gunn JKL, Pandarangga S, Yowi LRK, Hobgen S, et al. Knowledge, Attitudes, and Practices of Anopheles Mosquito Control Through Insecticide Treated Nets and Community-Based Health Programs to Prevent Malaria in East Sumba Island, Indonesia. PLoS Global Public Health. 2022;2 (9):e0000241. https://doi.org/10.1371/journal.pgph.0000241
31. Anders KL, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Andari B, et al. The AWED Trial (Applying Wolbachia to Eliminate Dengue) to Assess the Efficacy of Wolbachia-Infected Mosquito Deployments to Reduce Dengue Incidence in Yogyakarta, Indonesia: Study Protocol for A Cluster Randomised Controlled Trial. Trials. 2018;19 (302). https://doi.org/10.1186/s13063-018-2670-z
32. Brady OJ, Kharisma DD, Wilastonegoro NN, O’Reilly KM, Hendrickx E, Bastos LS, et al. The Cost-Effectiveness of Controlling Dengue in Indonesia Using wMel Wolbachia Released at Scale: a Modelling Study. BMC Medicine. 2020;18(186). https://doi.org/10.1186/s12916-020-01638-2
33. Rohani A, Fakhriy HA, Suzilah I, Zurainee MN, Najdah WMAW, Ariffin MM, et al. Indoor and Outdoor Residual Spraying of a Novel Formulation of Deltamethrin K-Othrine® (Polyzone) for The Control of Simian Malaria in Sabah, Malaysia. PLoS One. 2020;15(5):e0230860. https://doi.org/10.1371/journal.pone.0230860
34. AhbiRami R, Zuharah WF. School-Based Health Education for Dengue Control in Kelantan, Malaysia: Impact on Knowledge, Attitude and Practice. PLoS Neglected Tropical Diseases. 2020 Mar 27;14(3): e0008075. https://doi.org/10.1371/journal.pntd.0008075
35. Ahn J. Unequal Loneliness in The Digitalized Classroom: Two Loneliness Effects of School Computers and Lessons for Sustainable Education in the E-Learning Era. Sustainability. 2020;12(19). https://doi.org/10.3390/su12197889
36. Lai S, Farnham A, Ruktanonchai NW, Tatem AJ. Measuring Mobility, Disease Connectivity and Individual Risk: A Review of Using Mobile Phone Data and mHealth for Travel Medicine. Journal of Travel Medicine. 2019; 26(3). https://doi.org/10.1093/jtm/taz019
37. Meankaew P, Lawpoolsri S, Piyaphanee W, Wansatid P, Chaovalit P, Lawawirojwong S, et al. Cross-Platform Mobile App Development for Disseminating Public Health Information to Travelers in Thailand: Development and Usability. Tropical Diseases, Travel Medicine and Vaccines. 2022;8(17). https://doi.org/10.1186/s40794-022-00174-6
38. Farnham A, Baroutsou V, Hatz C, Fehr J, Kuenzli E, Blanke U, et al. Travel Behaviours and Health Outcomes During Travel: Profiling Destination-Specific Risks in A Prospective mHealth Cohort of Swiss Travellers. Travel Medicine and Infectious Disease. 2022;47(102294). https://doi.org/10.1016/j.tmaid.2022.102294
39. Sørensen HT. Patients with Chronic Diseases Who Travel: Need for Global Access to Timely Health Care Data. Clinical Epidemiology. 2022;14:513–519. https://doi.org/10.2147/CLEP.S360699
40. Muresu N, Sotgiu G, Are BM, Cossu A, Cocuzza C, Martinelli M, et al. Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature. International Journal of Environmental Research and Public Health. 2020;17(2). https://doi.org/10.3390/ijerph17020615
41. Allen V, Longley N. Infections in Immunosuppressed Travellers with Autoimmune Inflammatory Diseases-A Narrative Review and Advice for Clinical Practice. Rheumatology. 2021;60(9):3969–3976. https://doi.org/10.1093/rheumatology/keab445
42. Ahmed AM, Mohammed AT, Vu TT, Khattab M, Doheim MF, Ashraf Mohamed A, et al. Prevalence and Burden of Dengue Infection in Europe: A Systematic Review and Meta‐Analysis. Reviews in Medical Virology. 2020;30(2). https://doi.org/10.1002/rmv.2093
43. Agudelo Higuita NI, White BP, Franco-Paredes C, McGhee MA. An Update on Prevention of Malaria in Travelers. Therapeutic Advances in Infectious Disease. 2021;8. https://doi.org/10.1177/20499361211040690
44. Jaita S, Pisutsan P, Lawpoolsri S, Kitro A, Kittitrakul C, Kusolsuk T, et al. International University Students’ Pre-Travel Preparation, Knowledge and Practices Towards Travel Health in Thailand: A Nationwide Cross-Sectional Study. Tropical Medicine and Infectious Disease. 2023;8(6). https://doi.org/10.3390/tropicalmed8060322
45. Ariawan IGN, Swedarma KE, Yanti NPED. A Normative Behavior of Pre-Travel Health Consultation and the Associated Factors Among Travelers. Jurnal Ners. 2021;16(1): 26–34. https://doi.org/10.20473/jn.v16i1.21443
46. Nemhauser J. Preparing International Travelers. In: Nemhauser JB, editor. CDC Yellow Book 2024 [Internet]. 1st ed. New York: Oxford University Press; 2023. https://academic.oup.com/book/45769/chapter/399173231
47. Kain D, Findlater A, Lightfoot D, Maxim T, Kraemer MUG, Brady OJ, et al. Factors Affecting Pre-Travel Health Seeking Behaviour and Adherence to Pre-Travel Health Advice: A Systematic Review. Journal of Travel Medicine. 2019;26(6). https://doi.org/10.1093/jtm/taz059
48. Liew CH, Flaherty GT. Pre-travel Health Advice for Patients with Cardiovascular Disease. International Journal of Travel Medicine and Global Health. 2019;7(3):79–85. https://www.ijtmgh.com/article_92589.html
49. Ma T, Heywood A, MacIntyre CR. Travel Health Risk Perceptions of Chinese International Students in Australia – Implications for COVID-19. Infection, Disease & Health. 2020;25(3):197–204. https://doi.org/10.1016/j.idh.2020.03.002
50. Leder K, Borwein S, Chanthavanich P, Chatterjee S, Htun K, Marma ASP, et al. Travel Medicine Perspectives of Select Travel Medicine Experts Practicing in The Asia-Pacific Region. Journal of Travel Medicine. 2017;24(4). https://doi.org/10.1093/jtm/tax012
51. Sohail A, Akritidis J, McGuinness S, Leder K. Perceptions of Travel-Related Health Risks and Pre-Travel Health-Seeking Behaviour Among Students: A Qualitative Analysis. Travel Medicine and Infectious Disease. 2023;52(102532). https://doi.org/10.1016/j.tmaid.2022.102532
52. Sastre RP, Phakdee-Auksorn P. Examining Tourists’ Push and Pull Travel Motivations and Behavioral Intentions: The Case of British Outbound Tourists to Phuket, Thailand. Journal of Quality Assurance in Hospitality & Tourism. 2017;18(4):437–464. https://doi.org/10.1080/1528008X.2016.1250242
53. Brandano MG, Osti L, Pulina M. How Motivations and Satisfaction Influence Wine Tourists’ Loyalty? An Analysis of The Italian Case. International Journal of Culture Tourism and Hospitality Research. 2019;13 (1):55–69. https://doi.org/10.1108/IJCTHR-04-2018-0054
54. Shi X, Day J, Gordon S, Cai L, Adler H. An Exploratory Study of Visitors’ Motivations at A Heritage Destination: The Case of The South Luogu Alley in China. Journal of Hospitality and Tourism Insights. 2019;2(2): 186–202. https://doi.org/10.1108/JHTI-07-2018-0041
55. Fathoni M, Usman F, Hariyani S, Kurniawan EB, Yusuh A, Waloejo CS. Health Disaster Preparedness Using Android Mobile Based Application Case Mount Bromo Eruption. Jurnal Ners. 2020;15(1Sp):173–177. https://doi.org/10.20473/jn.v15i1Sp.19005
56. Felkai P. Analysis of Prevention in Travellers Diseases on The Basis of Latest Results in Travel Medicine. Orvosi Hetilap. 2008;149(36):1707–1712. https://doi.org/10.1556/oh.2008.28434
57. Gu D, He J, Sun J, Shi X, Ye Y, Zhang Z, et al. The Global Infectious Diseases Epidemic Information Monitoring System: Development and Usability Study of an Effective Tool for Travel Health Management in China. JMIR Public Health and Surveillance. 2021;7(2):e24204. https://doi.org/10.2196/24204
58. Kytö M, Koivusalo S, Ruonala A, Strömberg L, Tuomonen H, Heinonen S, et al. Behavior Change App for Self-Management of Gestational Diabetes: Design and Evaluation of Desirable Features. JMIR Human Factors. 2022;9(4):e36987. https://doi.org/10.2196/36987
59. Aboueid S, Meyer SB, Wallace JR, Mahajan S, Nur T, Chaurasia A. Use of Symptom Checkers for COVID-19-Related Symptoms Among University Students: A Qualitative Study. BMJ Innovations. 2021;7(2):253–260. https://doi.org/10.1136/bmjinnov-2020-000498
Authors
Copyright (c) 2025 by author
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, such as electronic, electrostatic and mechanical copies, photocopies, recordings, magnetic media, etc.
All articles published Open Access are free for everyone to read and download. Under the CC-BY-NC-SA license, authors retain ownership of the copyright for their article, but authors grant others permission to use the content of publications in Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin in whole or in part provided that the original work is properly cited. Users (redistributors) of Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin are required to cite the original source, including the author's names, Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin as the initial source of publication, year of publication, and volume number.
Media Kesehatan Masyarakat Indonesia Universitas Hasanuddin is licensed under Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.